While it seeks emergency use authorization for its molecular diagnostic test to detect the coronavirus that causes Covid-19, Talis Biomedical Corp. plans an initial public offering.
The Menlo Park company didn’t say in a Securities and Exchange Commis… […]
Eli Lilly’s $1.04 billion takeover of Prevail Therapeutics is officially complete, the company announced Friday.
The sides had entered into the buyout agreement last month with Lilly focusing on Prevail’s pipeline of gene therapies, highlighting two AA… […]
Jonathan Weissman’s team watched the cancer cells spread across the doomed mouse. Engineered with a bioluminescent enzyme, they appeared in scans first as a small navy blue diamond lodged near the heart; a week later, as a triangle splayed across the m… […]
Roche and their big sub Genentech have just recruited a top cancer specialist at Yale to head up global product development in oncology and hematology. I just got word that the pharma giant, which leads one of the most active cancer research operations… […]
CHICAGO–(BUSINESS WIRE)–SG Blocks, Inc. (NASDAQ: SGBX) (“SG Blocks” or the “Company”), a leading designer, innovator and fabricator of container-based structures, announced today that its Clarity Mobile Ventures (“CMV”) joint venture partnership with… […]
Diem Nguyen considers herself a “point of inflection seer.”
Helping businesses strategize and scale up is “where my sweet spot is,” the Pfizer veteran said. So when she was tapped to take the helm at gene therapy-focused Xalud Therapeutics,… […]